More U.S. Employers Plan to Stop Covering Weight-Loss Drugs by 2027
A growing number of companies in the United States are planning to stop providing insurance coverage for popular weight-loss medications by 2027. This decision comes as businesses face rising healthcare costs across the country.
Weight-loss drugs, such as Wegovy and Zepbound, have become very popular in recent years. However, these medications are expensive for employers to provide. As the number of employees using these treatments increases, many companies are finding it difficult to manage the high monthly costs associated with these prescriptions.
Industry experts note that while these drugs offer significant health benefits for many patients, the financial burden on company insurance plans is becoming unsustainable for some organizations. As a result, human resources departments are re-evaluating their benefits packages to keep overall healthcare spending under control.
This trend highlights the ongoing challenge of balancing employee health needs with the rising costs of medical care in the U.S. As 2027 approaches, many workers may need to prepare for changes in their insurance coverage regarding these specific treatments.